MedPath

CEPTAZ INJECTION - PWS IV 10GM/VIAL

CEPTAZ INJECTION - PWS IV 10GM/VIAL

Discontinued
DIN Number

02213737

Drug Class

Human

Market Date

Nov 7, 2001

Company
HC

GlaxoSmithKline Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02213737
AIG Number0116900005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01DD02 CEFTAZIDIME
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification08:12.06.12
Health Canada Classification

ACTIVE INGREDIENTS (1)

CEFTAZIDIMEActive
Strength: 10 G / VIAL
Monograph: CEFTAZIDIME

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.